Widukind Lenz
From Wikipedia, the free encyclopedia
Widukind Lenz (1919–1995) was a distinguished German pediatrician, medical geneticist and dysmorphologist who was among the first to recognize the thalidomide syndrome in 1961 and alert the world to the dangers of limb and other malformations due to the mother's exposure to this drug during pregnancy.
In the ensuing years, Lenz did much important work on the thalidomide syndrome[1]. He also did work of value in clinical genetics and cytogenetics. He described a number of malformation syndromes, several of which bear his name today.[2] He was an editor of the journal Human Genetics and published a textbook of medical genetics.
Lenz studied medicine from 1937 to 1943. He was a physician in Luftwaffe hospitals during World War II and then in a prisoner-of-war camp in England. After stints in biochemistry in Göttingen and medicine in Kiel, he became physician-in-chief of the Eppendorfer Kinderklinik in 1952 and was named to the chair of pediatrics at the University of Hamburg in 1961. Lenz became director of the Institute of Human Genetics in Münster in 1965.
Widukind Lenz was the son of Fritz Lenz, also a geneticist, but one of an entirely different stripe. Fritz Lenz espoused eugenics and influenced the racial hygiene policies of the Third Reich. Widukind Lenz died respected as an eminent physician and a humanitarian.
[edit] External links
- Dr. Widukind Lenz: History of Contergan (Thalidomide) Extract from a lecture by Widukind Lenz on the history of Contergan (Thalidomide) given at the 1992 UNITH Congress -- with a photograph of Widukind Lenz
- Information on the life and contributions of Widukind Lenz and the thalidomide syndrome, by Ole Daniel Enersen on the Whonamedit site
